Last reviewed · How we verify
NCT07448805
Accuracy and Safety of the Syai Tag System for Continuous Glucose Monitoring in Intensive Internal Care Unit
NA trial testing continuous glucose monitor in Diabetes Mellitus in 100 participants. Currently enrolling.
15 February 2027
Quick facts
| Lead sponsor | University Medical Centre Maribor |
|---|---|
| Phase | NA |
| Status | Recruiting now |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | device feasibility |
| Enrollment | 100 |
| Start date | 18 February 2026 |
| Primary completion | 15 February 2027 |
| Estimated completion | 15 May 2027 |
| Sites | 1 location across Slovenia |
Drugs / interventions tested
- continuous glucose monitor
Conditions studied
- Diabetes Mellitus — all drugs for Diabetes Mellitus →
- Blood Sugar — all drugs for Blood Sugar →
- Sepsis — all drugs for Sepsis →
- Critically Ill Intensive Care Unit Patients — all drugs for Critically Ill Intensive Care Unit Patients →
Sponsor
University Medical Centre Maribor
Who can join
18 and older, any sex, with Diabetes Mellitus or Blood Sugar. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Researchers at the Department of Intensive Internal Medicine and the Department of Endocrinology and Diabetology will conduct a study to verify the accuracy and safety of the new Syai Tag system for continuous glucose monitoring in patients in intensive internal care. Almost 150,000 people in Slovenia have diabetes, so keeping a close eye on blood sugar levels is key to preventing complications. The new sensors for continuous monitoring are available over the counter and certified as medical devices. The study will include at least 100 patients who will need blood sugar monitoring during their stay in the intensive care unit. Each patient will have two small sensors placed on each upper arm to continuously measure their blood sugar levels, but these values will not be visible to medical staff. At the same time, healthcare professionals will perform routine blood sugar measurements, and researchers will then compare the accuracy of both methods. The procedure is safe and painless, and patients will receive the same quality of care as usual.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07448805
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of continuous glucose monitor
Trials testing the same drug.
- NCT07174245 — Pregnancy and Postpartum CGM in GDM · recruiting
Other recruiting trials for Diabetes Mellitus
Currently open trials in the same condition.
- NCT07238556 — A Novel Digital Tool Physicians Can Use to Prescribe Exercise to Patients With Cardiovascular Disease Risk Factors · NA · recruiting
- NCT07392437 — Prevalence of Diabetes-related Distress Among Patients Living With Type 2 Diabetes in a University Hospital Center and I · NA · recruiting
- NCT07425275 — Integrated Oral Care Intervention for Xerostomia in Diabetes Patients · NA · recruiting
- NCT06918977 — Improving Glycemic Control With Telemedicine and Smart Insulin Pens · NA · recruiting
- NCT07039357 — Reconfirming the Safety and Performance of the Glyconics-DS System in Known Populations With and Without Diabetes · NA · active not recruiting
Other University Medical Centre Maribor trials
Trials by the same sponsor.
- NCT07123857 — Impact of Point-of-care Lactate Testing as Triage Supplement on Patient Management Using Manchester Triage System · NA · recruiting
- NCT06539234 — Angiotensin II Stress Test. Renin Kinetics During Treatment of Vasoplegic Shock With Angiotensin II. · recruiting
- NCT06477757 — Inflammatory Response and Oxidative Stress in Cardiac Surgery: Min. Invasive vs. Conventional Extracorporeal Circulation · NA · not yet recruiting
- NCT06776302 — Assessment of Brain Damage Using Monitoring of Cerebral Oximetry Dynamics in Patients After Cardiac Arrest · NA · recruiting
- NCT06155812 — Multimodal Vasopressor Strategy in Septic Shock · Phase 2, PHASE3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07448805 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by University Medical Centre Maribor
- Last refreshed: 4 March 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07448805.